Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate. 2007

Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
Division of Cellular Biochemistry, Centre for Biomedical Genetics, The Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.

Cell-cell communication through connexin43 (Cx43)-based gap junction channels is rapidly inhibited upon activation of various G protein-coupled receptors; however, the mechanism is unknown. We show that Cx43-based cell-cell communication is inhibited by depletion of phosphatidylinositol 4,5-bisphosphate (PtdIns[4,5]P(2)) from the plasma membrane. Knockdown of phospholipase Cbeta3 (PLCbeta3) inhibits PtdIns(4,5)P(2) hydrolysis and keeps Cx43 channels open after receptor activation. Using a translocatable 5-phosphatase, we show that PtdIns(4,5)P(2) depletion is sufficient to close Cx43 channels. When PtdIns(4,5)P(2) is overproduced by PtdIns(4)P 5-kinase, Cx43 channel closure is impaired. We find that the Cx43 binding partner zona occludens 1 (ZO-1) interacts with PLCbeta3 via its third PDZ domain. ZO-1 is essential for PtdIns(4,5)P(2)-hydrolyzing receptors to inhibit cell-cell communication, but not for receptor-PLC coupling. Our results show that PtdIns(4,5)P(2) is a key regulator of Cx43 channel function, with no role for other second messengers, and suggest that ZO-1 assembles PLCbeta3 and Cx43 into a signaling complex to allow regulation of cell-cell communication by localized changes in PtdIns(4,5)P(2).

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008959 Models, Neurological Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Neurologic Models,Model, Neurological,Neurologic Model,Neurological Model,Neurological Models,Model, Neurologic,Models, Neurologic
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010750 Phosphoproteins Phosphoprotein
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
June 2005, Current opinion in neurobiology,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
January 2010, Traffic (Copenhagen, Denmark),
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
December 2007, Experimental cell research,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
January 2007, Handbook of experimental pharmacology,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
January 2018, Scientific reports,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
September 2018, Biochemical and biophysical research communications,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
February 1998, Biochemical pharmacology,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
January 2004, Current topics in microbiology and immunology,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
August 2007, The Journal of physiology,
Leonie van Zeijl, and Bas Ponsioen, and Ben N G Giepmans, and Aafke Ariaens, and Friso R Postma, and Péter Várnai, and Tamas Balla, and Nullin Divecha, and Kees Jalink, and Wouter H Moolenaar
September 2003, Circulation research,
Copied contents to your clipboard!